PCYOX1L
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
prenylcysteine oxidase 1 like | Ensembl:ENSG00000145882 | HGNC:HGNC:28477 | PA147357517 | 5q32 |
Gene Categories:
DRUGGABLE GENOMEGO terms in PCYOX1L
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | TAS | GO:0005576 | extracellular region |
CC | HDA | GO:0016020 | membrane |
CC | TAS | GO:0031093 | platelet alpha granule lumen |
BP | TAS | GO:0002576 | platelet degranulation |
BP | IBA | GO:0030327 | prenylated protein catabolic process |
BP | IBA | GO:0030328 | prenylcysteine catabolic process |
BP | IEA | GO:0055114 | oxidation-reduction process |
MF | IBA | GO:0001735 | prenylcysteine oxidase activity |
Gene expression in normal tissue: PCYOX1L
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PCYOX1L
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-109582 | Hemostasis |
reactome | R-HSA-114608 | Platelet degranulation |
reactome | R-HSA-76002 | Platelet activation, signaling and aggregation |
reactome | R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in PCYOX1L